Trial · NCT00910429
Outcomes28
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 28
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With Treatment-emergent Adverse Events (TEAE) | From administration of first dose of study medication up to 2 days after end of treatment with study medication, up to 10 years | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Number of Participants With Death | From baseline to end of safety follow-up visit, up to 10 years (1 month more than End of study visit) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Percentage of Participants With Treatment-emergent High Laboratory Abnormalities in Hematology and Coagulation | From baseline to Termination visit, up to 10 years | Participants in SAF with evaluable data for each visit, and for each parameter. | Percentage | NUMBER |
| SECONDARY | Percentage of Participants With Treatment-emergent Low Laboratory Abnormalities in Hematology and Coagulation | From baseline to Termination visit, up to 10 years | Participants in SAF with evaluable data for each visit, and for each parameter. | Percentage | NUMBER |
| SECONDARY | Change From Baseline of Hemoglobin in Hematology and Coagulation | From baseline to Termination visit, up to 10 years | Participants in SAF with evaluable data for each visit | gram/deciliter (g/dL) | MEAN |
| SECONDARY | Percentage of Participants With Treatment-emergent High Laboratory Abnormalities in Clinical Chemistry | From baseline to Termination visit, up to 10 years | Participants in SAF with evaluable data for each visit, and for each parameter. | Percentage | NUMBER |
| SECONDARY | Percentage of Participants With Treatment-emergent Low Laboratory Abnormalities in Clinical Chemistry | From baseline to Termination visit, up to 10 years | Participants in SAF with evaluable data for each visit, and for each parameter. | Percentage | NUMBER |
| SECONDARY | Change From Baseline of Urate in Clinical Chemistry | From baseline to Termination visit, up to 10 years | Participants in SAF with evaluable data for each visit | milligram/deciliter (mg/dL) | MEAN |
| OTHER_PRE_SPECIFIED | Change of Systolic Blood Pressure (SBP) | From baseline to Termination visit, up to 10 years | Participants in SAF with evaluable data for each visit | millimetre(s) of mercury (mmHg) | MEAN |
| OTHER_PRE_SPECIFIED | Change of Diastolic Blood Pressure (DBP) | From baseline to Termination visit, up to 10 years | Participants in SAF with evaluable data for each visit | mmHg | MEAN |
| OTHER_PRE_SPECIFIED | Change of Heart Rate | From baseline to Termination visit, up to 10 years | Participants in SAF with evaluable data for each visit | beats/minute (BPM) | MEAN |
| OTHER_PRE_SPECIFIED | Change of Weight | From baseline to Termination visit, up to 10 years | Participants in SAF with evaluable data for each visit | kilogram (kg) | MEAN |
| OTHER_PRE_SPECIFIED | Change of Oxygen Saturation (SaO2) | From baseline to Termination visit, up to 10 years | Participants in SAF with evaluable data for each visit | Percentage | MEAN |
| OTHER_PRE_SPECIFIED | Change of Arterial Partial Oxygen Pressure (PaO2) | From baseline to Termination visit, up to 10 years | Participants in SAF with evaluable data for each visit | mmHg | MEAN |
| OTHER_PRE_SPECIFIED | Change of Arterial Partial Pressure of Carbon Dioxide (PaCO2) | From baseline to Termination visit, up to 10 years | Participants in SAF with evaluable data for each visit | mmHg | MEAN |
| OTHER_PRE_SPECIFIED | Change of RR Duration From Electrocardiogram (ECG) | From baseline to Month 48 | Participants in SAF with evaluable data for each visit | millisecond (msec) | MEAN |
| OTHER_PRE_SPECIFIED | Change of PR Duration From ECG | From baseline to Month 48 | Participants in SAF with evaluable data for each visit | msec | MEAN |
| OTHER_PRE_SPECIFIED | Change of QRS Duration From ECG | From baseline to Month 48 | Participants in SAF with evaluable data for each visit | msec | MEAN |
| OTHER_PRE_SPECIFIED | Change of QT Duration in ECG | From baseline to Month 48 | Participants in SAF with evaluable data for each visit | msec | MEAN |
| OTHER_PRE_SPECIFIED | Change in Six-minute Walking Distance (6MWD) Test | From baseline to End of study visit, up to 10 years | Participants in SAF with evaluable data for each visit | meters | MEDIAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00910429/outcomes